Daniel Schlingman is a strategic and innovative leader serving as the Manager of Product Development at Abbott since 2021. In this role, they lead the development of blood screening assays and work closely with senior management to shape budget and strategy. Prior to this, Daniel held various research and leadership positions at Illumina and participated in significant academic research at institutions like Yale University and Stanford University. Daniel earned a Bachelor of Science in Biochemistry from the University of New Mexico and a Ph.D. in Molecular Biophysics and Biochemistry from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices